zotiraciclib (TG02)

News alerts, weekly reports and conference planners

Company:

Adastra Pharma, Cothera Biosci, S*BIO

Drug class:

CDK9 inhibitor

Related drugs:

IDH2 mutation	Glioma	IDH2 mutation	Glioma	TG02 Sensitive: C2 – Inclusion Criteria TG02 Sensitive : C2	TG02 Sensitive: C2 – Inclusion Criteria TG02 Sensitive : C2
IDH1 mutation	Glioma	IDH1 mutation	Glioma	TG02 Sensitive: C3 – Early Trials TG02 Sensitive : C3	TG02 Sensitive: C3 – Early Trials TG02 Sensitive : C3

Associations
(2)